APERAM S.A. NY SHS/1 O.N. (F:7AAN) — Stock Price
APERAM S.A. NY SHS/1 O.N. (F:7AAN) is currently trading at €44.40 EUR, down 0.45% today. Over the past 52 weeks, shares have ranged between €27.20 and €52.50. This page tracks APERAM S.A. NY SHS/1 O.N.'s live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is APERAM S.A. NY SHS/1 O.N. worth.
APERAM S.A. NY SHS/1 O.N. (7AAN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks APERAM S.A. NY SHS/1 O.N.'s daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
APERAM S.A. NY SHS/1 O.N. Income Statement — Revenue, Profit & Earnings by Year
APERAM S.A. NY SHS/1 O.N.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €6.08 Billion | €6.25 Billion | €6.59 Billion | €8.16 Billion |
| Cost of Revenue | €5.74 Billion | €5.81 Billion | €6.21 Billion | €6.98 Billion |
| Gross Profit | €341.00 Million | €449.00 Million | €379.00 Million | €1.18 Billion |
| Research & Development | — | — | — | — |
| SG&A | €120.00 Million | €117.00 Million | €109.00 Million | €108.00 Million |
| Total Operating Expenses | €6.06 Billion | €6.13 Billion | €6.50 Billion | €7.27 Billion |
| Operating Income | €16.00 Million | €129.00 Million | €89.00 Million | €890.00 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €63.00 Million | €47.00 Million | €43.00 Million | €22.00 Million |
| Income Before Tax | €-75.00 Million | €78.00 Million | €117.00 Million | €752.00 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €9.00 Million | €231.00 Million | €203.00 Million | €625.00 Million |
APERAM S.A. NY SHS/1 O.N. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes APERAM S.A. NY SHS/1 O.N.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €5.17 Billion | €5.84 Billion | €6.21 Billion | €6.26 Billion |
| Total Current Assets | €1.94 Billion | €2.87 Billion | €3.30 Billion | €3.67 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €435.00 Million | €384.00 Million | €429.00 Million | €454.00 Million |
| Inventory | €1.43 Billion | €2.16 Billion | €2.28 Billion | €2.59 Billion |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €464.00 Million | €412.00 Million | €434.00 Million | €429.00 Million |
| Total Liabilities | €1.97 Billion | €2.47 Billion | €2.76 Billion | €2.87 Billion |
| Total Current Liabilities | €615.00 Million | €1.67 Billion | €1.85 Billion | €1.86 Billion |
| Long-term Debt | €973.00 Million | €434.00 Million | €490.00 Million | €583.00 Million |
| Net Debt | €857.00 Million | €443.00 Million | €391.00 Million | €371.00 Million |
| Total Stockholder Equity | €3.19 Billion | €3.35 Billion | €3.44 Billion | €3.38 Billion |
| Retained Earnings | €2.78 Billion | €2.91 Billion | €2.82 Billion | €2.74 Billion |
APERAM S.A. NY SHS/1 O.N. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how APERAM S.A. NY SHS/1 O.N. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €422.00 Million | €280.00 Million | €471.00 Million | €642.00 Million |
| Capital Expenditures | €174.00 Million | €155.00 Million | €301.00 Million | €296.00 Million |
| Free Cash Flow | €248.00 Million | €125.00 Million | €170.00 Million | €346.00 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €145.00 Million | €145.00 Million | €145.00 Million | €151.00 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €259.00 Million | €229.00 Million | €204.00 Million | €186.00 Million |
| Change in Cash | €109.00 Million | €-227.00 Million | €-14.00 Million | €-67.00 Million |
APERAM S.A. NY SHS/1 O.N. Earnings History — EPS Actual vs. Analyst Estimates
Track APERAM S.A. NY SHS/1 O.N.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 28, 2026 | — | — | — |
| Feb 05, 2026 | — | — | — |
| May 01, 2025 | — | — | — |
| Feb 07, 2025 | — | — | — |
| Nov 08, 2024 | — | — | — |